Literature DB >> 1418509

Microskin autograft with pigskin xenograft overlay: a preliminary report of studies on patients.

S D Lin1, C S Lai, C K Chou, C W Tsai, K F Wu, C W Chang.   

Abstract

Split-thickness pigskin graft (STPSG) was used to replace allograft skin for microskin grafting in 16 patients, nine of whom were burn patients, five suffered from traumatic defects and two from diabetic ulcers. The expansion ratios used in these patients ranged from 8:1 to 12:1. The STPSG preparation described was found to be safe for clinical application. The autogenous donor skin was excised from the inguinal area, and the donor site was primarily closed. There were no instances of donor site morbidity. The majority of the STPSG overlays adhered to the wound firmly. Histological examination showed that the microskin grafts proliferated actively immediately beneath the STPSG overlay. The time for the wound to be fully resurfaced varied from 13 to 21 days depending on the expansion ratio employed. There were only two episodes of pseudomonas infection and no further grafting was required in any of the patients. In this study the pigskin xenograft was found to provide a suitable environment for the epithelialization of microskin autografts. When allograft is not available, this is an alternative way of ensuring successful microskin grafting.

Entities:  

Mesh:

Year:  1992        PMID: 1418509     DOI: 10.1016/0305-4179(92)90155-n

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  3 in total

Review 1.  The micrograft concept for wound healing: strategies and applications.

Authors:  Atanu Biswas; Manish Bharara; Craig Hurst; David G Armstrong; Horacio Rilo
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

Review 2.  Neonatal burn injuries: an agony for the newborn as well as the burn care team.

Authors:  M Saaiq; S Ahmad; S Zaib
Journal:  Ann Burns Fire Disasters       Date:  2013-12-31

3.  The MEEK technique: 10-year experience at a tertiary burn centre.

Authors:  Abdulaziz Almodumeegh; Paul I Heidekrueger; Milomir Ninkovic; Johannes Rubenbauer; Ektoras Hadjipanayi; P Niclas Broer
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.